Twitter Linkedin-in

Biologics Series

April 2021 | London, UK
Menu
Book Now

If you are looking for the 2020 event, Biologics Series: Virtual, please click here

Biologics SeriesApril 2021 | London, UK

ENGAGE, EDUCATE & ELEVATE

Download Agenda
Register

Europe’s Premier Meeting for Biologics R&D

ENGAGE with peers and selected leading providers in an exciting, successful networking environment

EDUCATE yourself on the latest in research and innovation in our renowned conference programme

ELEVATE your biologics research through immersive, discussion-based sessions within a committed community

Notice: Health & Safety Guidelines regarding COVID-19

Programmes

Proteins & Antibodies

An industry-leading programme offering abundant learning, knowledge-sharing & partnership building opportunities in protein & antibody engineering, biotherapeutics development and bioanalysis.

Peptides & Oligonucleotides

Bringing together leaders from across the industry, the event features unparalleled opportunities to discuss, debate and hear from the latest peptides research, from manufacturing, chemistry & analytical technologies through to therapeutics success stories; together with insights into oligonucleotide research.

Bispecifics in Discovery & Development

In line with current industry trends, our new event will address the latest advancements in bispecifics discovery, therapeutic development and application.

Digital Workshops

You don't have to wait until August to get involved - register for our complimentary digital workshops here. Presented by expert speakers from leading pharmaceutical companies, these workshops will give you advanced insights into topic areas that the event will address.

Key Speakers

The 2021 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

Below were some of the speakers of the 2020 Series:

Ekkehard Leberer

Ekkehard Leberer

Senior Director
Sanofi

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of on-site experiences.

Kick-Off Sessions

Launching the event in 2020 is a new range of closed-door interactive sessions covering the key focus areas in Biologics research
Find Out More

Poster Display

Enhance your attendance with an A0 Poster, based in our main networking hall
Submit Abstract

Event App

Helping you get more from the event with networking features, searchable presentations & attendees, and much more
Read More

Sponsorship

A range of customisable opportunities for lead generation, brand building and global business deals. Whether you’re looking to build business, product launch or increase visibility, we provide a variety of highly effective options to suit budget and requirement.
Download Brochure
“I liked the mix of presentation topics, and the quality of the talks. The size of the meeting was good, as was the networking time"
Vice President InnovationDuPont
"Topics were of high interest. I liked the opportunity to network and interact with key industry partners. Great presentations - fantastic learning opportunity."
ScientistSanofi
"The event was well organized, with a great line of prominent and knowledgeable speakers.I liked that there was also enough time for networking."
Senior Vice President, Drug DiscoveryTaros
"The talks were a very high quality and had some excellent feedback. The lunch was good and the layout made people interact."
Sales ManagerFortéBio Biologics
"The 8+ hours of networking time allowed optimal time for discussions linked with the pre-organised meetings."
Inside Sales ManagerBio-Techne
Previous
Next
Biologics Post-Event Report
Biologics 2019 Post-Event Report
Statistics, feedback, photos and more from last year's event.
affilogic webinar
Complimentary Webinar
Webinar on 'Nanofitin-Antibody fusion as a novel multispecific platform. Hosted by Mathieu Cinier, Scientific Director, Affilogic.
Thomas Novo Nordisk
Bioconjugation and New Target Discovery
Q&A with Novo Nordisk's Scientific Director, Thomas Hoeg-Jensen
Zealand Webinar
Complimentary Webinar
From Andy Parker, Senior Vice President & Chief Scientific Officer, Zealand Pharma: From Peptide Discovery to Phase 3 – A Zealand Perspective
Tony Evox
Q&A Session with Antonin De Fougerolles
Chief Executive Officer of Evox Therapeutics, Antonin De Fougerolles: The Role of Bispecific Antibodies within the Healthcare Industry
Content Hub Graphic
Oxford Global Content HUB
Access complementary resources including Webinars, Q&A Sessions, Newsletters and much more.

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Virtual Events

In-Person Events

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.